Kala azar, or visceral leishmaniasis, is a formidable parasitic disease transmitted by sandflies. The ailment manifests through fever, significant weight loss, and an enlarged spleen and liver, posing a serious health risk in affected areas.
India has been proactive in its fight against Ambaji Kala azar, employing a range of strategies to curtail its spread. These include effective indoor residual spraying, improving construction to deter sandfly breeding, and utilizing the antimicrobial drug amphotericin B for treatment.
Initially, India aimed to eliminate Kala azar by 2015. However, extensions have been necessary, and current projections suggest the disease could be eradicated by the end of 2023.
Several challenges persist in eliminating Kala azar. Ensuring effective spraying, monitoring the construction of 'kuccha' walls, and guaranteeing complete treatment of infected individuals with PKDL are critical to preventing disease transmission.
Eliminating this disease is vital for reducing mortality and morbidity rates, thereby enhancing the overall health standards in afflicted regions.
Bihar, Jharkhand, West Bengal, and Uttar Pradesh have historically borne the brunt of Kala azar. These states, particularly certain districts within them, remain the focal point of intensive eradication efforts.
Several factors contribute to the susceptibility of these regions to Kala azar, including the prevalence of the sandfly vector, inadequate housing conditions that support sandfly breeding, and limited access to medical treatment. The warm, humid climate also fosters an ideal environment for sandfly proliferation, complicating eradication efforts.
While India has made significant strides in combating Kamini Kaushal Kala azar, the journey toward complete elimination is ongoing. Addressing the challenges and leveraging strategic interventions are key to achieving the 2023 target.
Kutos : AI Assistant!
